Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 2/20 | 1.00 |
| ▸ | KCNA2 | P16389 | 2/20 | 0.67 |
| ▸ | KCNA4 | P22459 | 2/20 | 0.67 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.67 |
| ▸ | KCNA1 | Q09470 | 2/20 | 0.67 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.67 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12132132 | 0.91 | KCNA3 (0.83) | KCNA3KCNA2KCNA4KCNA5KCNA1 | |
| SCHEMBL12133188 | 0.91 | KCNA3 (0.83) | KCNA3KCNA2KCNA4KCNA5KCNA1 | |
| SCHEMBL12133299 | 0.89 | KCNA3 (0.80) | KCNA3KCNA2KCNA4KCNA5KCNA1 | |
| SCHEMBL10884152 | 0.89 | KCNA3 (0.80) | KCNA3KCNA2KCNA4KCNA5KCNA1 | |
| SCHEMBL9678430 | 0.89 | KCNA3 (0.80) | KCNA3KCNA2KCNA4KCNA5KCNA1 | |
| SCHEMBL3612862 | 0.88 | KCNA3 (0.78) | KCNA3KCNA2KCNA4KCNA5KCNA1 | |
| SCHEMBL10300854 | 0.88 | KCNA3 (0.78) | KCNA3KCNA2KCNA4KCNA5KCNA1 | |
| SCHEMBL12133427 | 0.88 | KCNA3 (0.78) | KCNA3KCNA2KCNA4KCNA5KCNA1 | |
| SCHEMBL9127225 | 0.88 | KCNA3 (0.78) | KCNA3 | |
| SCHEMBL10821323 | 0.87 | KCNA3 (0.78) | KCNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2026-02-05 | — | — | US | disclosed |
| US-12427176-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2025-09-30 | — | — | US | disclosed |
| US-20240216456-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240216457-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-07-04 | — | — | US | disclosed |
| US-20240207344-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| US-20240207342-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-06-27 | — | — | US | disclosed |
| EP-4346848-A2 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | Rizun, Nodari (US) | 2024-04-10 | — | — | EP | disclosed |
| US-20240108676-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2024-04-04 | — | — | US | disclosed |
| US-11883454-B2 | Enriched mineral pitch resin products and methods of manufacturing enriched mineral pitch resin products | RIZUN NODARI (US) | 2024-01-30 | — | — | US | disclosed |
| US-20230405067-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | RIZUN NODARI (US) | 2023-12-21 | — | — | US | disclosed |
| EP-0095835-A1 | Preparing 4,7-dialkoxybenzofurans, and intermediates used therein | THE UPJOHN COMPANY (US) | 1983-12-07 | — | — | EP | disclosed |
| EP-0094769-A1 | Preparing 7-alkoxybenzofurans and intermediates used therein | THE UPJOHN COMPANY (US) | 1983-11-23 | — | — | EP | disclosed |
| US-4412071-A | Antiatherosclerotic compositions | THE UPJOHN COMPANY (US) | 1983-10-25 | — | — | US | disclosed |
| US-4399146-A | Treatment of atherosclerosis with khellin-related furochromones | THE UPJOHN COMPANY (US) | 1983-08-16 | — | — | US | disclosed |
| US-4313881-A | 5-Hydroxyfurochromones | THE UPJOHN COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| US-4313882-A | 7-Methyl-6-methylthio-, methylsulfinyl-, and methylsulfonyl-methyl-furochromones | THE UPJOHN COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| US-4313883-A | ANTHIATHEROSCLEROSIS | THE UPJOHN COMPANY (US) | 1982-02-02 | — | — | US | disclosed |
| US-4304722-A | Benzo[1,2-b:5,4-b']difuran-3(2H)-ones | THE UPJOHN COMPANY (US) | 1981-12-08 | — | — | US | disclosed |
| US-4284569-A | Antiatherosclerotic furochromones | THE UPJOHN COMPANY (US) | 1981-08-18 | — | — | US | disclosed |
| US-4281013-A | Antiatherosclerotic use of khellin and khellinin | THE UPJOHN COMPANY (US) | 1981-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260034186-A1 | ENRICHED MINERAL PITCH RESIN PRODUCTS AND METHODS OF MANUFACTURING ENRICHED MINERAL PITCH RESIN PRODUCTS | TRPV1, SOST, RUNX1 | KCNA3 3684/4885KCNA2 3642/4885KCNA4 3875/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.